BIOSCIENCE NEUTRACEUTICALS, INC. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
BIOSCIENCE NEUTRACEUTICALS, INC. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $13.96 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2018-05-14
- BIOSCIENCE NEUTRACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2018-03-31 was $13.96K, a 597.85% increase year-over-year.
- BIOSCIENCE NEUTRACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-06-30 was $12.58K.
- BIOSCIENCE NEUTRACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-03-31 was $2.00K.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month |
|---|---|---|
| 2018-03-31 | $13.96K 10-Q · filed 2018-05-14 | |
| 2017-06-30 | $12.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-10-11 | $14.58K 10-Q · filed 2017-10-11 |
| 2017-03-31 | $2.00K 10-Q · filed 2018-05-14 | |
| 2016-06-30 | $2.53K 10-Q · filed 2017-10-11 |